Trv Gp Iv, LLC Pliant Therapeutics, Inc. Call Options Transaction History
Trv Gp Iv, LLC
- $88.8 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLRX
# of Institutions
126Shares Held
56.7MCall Options Held
245KPut Options Held
86.7K-
Tang Capital Management LLC San Diego, CA6MShares$10.1 Million0.42% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.35 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.95MShares$6.63 Million0.16% of portfolio
-
Morgan Stanley New York, NY3.75MShares$6.31 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$5.06 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $81.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...